Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, Gao Q, Hasenfuß G, Kahwash R, Kaye DM, Litwin SE, Lurz P, Massaro JM, Mohan RC, Ricciardi MJ, Solomon SD, Sverdlov AL, Swarup V, van Veldhuisen DJ, Winkler S, Leon MB, REDUCE LAP-HF II investigators

Open source

DOI: 10.1016/s0140-6736(22)00016-2
Published: 2022 Mar 19
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-22-00016-2,
  title = {Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.},
  author = {Shah SJ and Borlaug BA and Chung ES and Cutlip DE and Debonnaire P and Fail PS and Gao Q and Hasenfuß G and Kahwash R and Kaye DM and Litwin SE and Lurz P and Massaro JM and Mohan RC and Ricciardi MJ and Solomon SD and Sverdlov AL and Swarup V and van Veldhuisen DJ and Winkler S and Leon MB and REDUCE LAP-HF II investigators},
  year = {2022},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(22)00016-2},
  url = {https://doi.org/10.1016/s0140-6736(22)00016-2}
}

RIS

TY  - JOUR
TI  - Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
AU  - Shah SJ
AU  - Borlaug BA
AU  - Chung ES
AU  - Cutlip DE
AU  - Debonnaire P
AU  - Fail PS
AU  - Gao Q
AU  - Hasenfuß G
AU  - Kahwash R
AU  - Kaye DM
AU  - Litwin SE
AU  - Lurz P
AU  - Massaro JM
AU  - Mohan RC
AU  - Ricciardi MJ
AU  - Solomon SD
AU  - Sverdlov AL
AU  - Swarup V
AU  - van Veldhuisen DJ
AU  - Winkler S
AU  - Leon MB
AU  - REDUCE LAP-HF II investigators
PY  - 2022
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(22)00016-2
UR  - https://doi.org/10.1016/s0140-6736(22)00016-2
ER  -

APA

SJ, S., BA, B., ES, C., DE, C., P, D., PS, F., Q, G., G, H., R, K., DM, K., SE, L., P, L., JM, M., RC, M., MJ, R., SD, S., AL, S., V, S., DJ, V. V., S, W., MB, L., & investigators, R. L. I. (2022). Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(22)00016-2

Source records

pubmed · retrieved 2026-09-25T14:45:33.587Z